Update in the pharmacologic treatment of diabetes: focus on insulin detemir, insulin glulisine, and inhaled dry powdered insulin.

The Diabetes educator

Volumn 33, Issue 2, 2007, Pages

  Iltz, Jason L ^a   Odegard, Peggy Soule ^a   Setter, Stephen M ^a   Campbell, R Keith ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; INSULIN DETEMIR; INSULIN GLULISINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIABETES MELLITUS; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; CLINICAL TRIALS; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS;

EID: 34447532560     PISSN: 01457217     EISSN: None     Source Type: Journal    
DOI: 10.1177/0145721707299264     Document Type: Article

References (0)